On August 28, 2018 Novavax, Inc. (NASDAQ: NVAX) reported that Novavax will participate in the B. Riley FBR Annual Healthcare Conference and the Citi 13th Annual Biotech Conference in September (Press release, Novavax, AUG 28, 2018, View Source [SID1234529100]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conference details are as follows:

B. Riley FBR Annual Healthcare Conference

Title: "Vaccine & Antibiotics Can’t Be Developed For Some Intractable Infectious Diseases"
Date and Time: Tuesday, September 4, 1:55 – 2:55 p.m.
Moderator: George Zavoico, B. Riley FBR
Panelists: Vivek Shinde, M.D., M.P.H., Executive Director of Clinical Development, Novavax
Robert Stein, M.D., Ph.D., Senior R&D Advisor, Agenus
Location: New York Marriott East Side

Citi 13th Annual Biotech Conference

Date: Thursday, September 6
Forum: Investor meetings
Location: Four Seasons Hotel Boston